Champions Oncology Ratios (2010-2026) | CSBR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Apr2021	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026
Profitability
Gross Margin (Quarter)	86.07%	52.05%	86.09%	88.26%	-46.52%	48.69%	47.88%	86.21%	43.86%	38.83%	42.82%	85.05%	207.75%	49.70%	44.93%	61.17%	41.15%	86.75%	51.70%	83.90%
EBT Margin (Quarter)	-6.07%	-1.40%	2.45%	6.05%	-2.69%	-2.20%	-0.01%	-18.96%	-19.44%	-20.21%	-17.80%	-20.96%	-1.36%	9.49%	5.48%	26.52%	-15.90%	-3.23%	1.70%	-1.43%
EBIT Margin (Quarter)	-6.13%	-1.56%	2.23%	6.29%	-2.42%	-2.07%	0.05%	-19.24%	-19.29%	-20.32%	-16.89%	-21.44%	-1.94%	9.45%	5.43%	26.40%	-16.24%	-3.77%	1.23%	-1.67%
EBITDA Margin (Quarter)	-6.13%	-1.56%	2.23%	6.29%	-2.42%	-2.07%	0.05%	-19.24%	-19.29%	-20.32%	-16.89%	-21.44%	-1.94%	9.45%	5.43%	26.40%	-16.24%	-3.77%	1.23%	-1.67%
Operating Margin (Quarter)	-6.13%	-1.56%	2.23%	6.29%	-2.42%	-2.07%	0.05%	-19.24%	-19.29%	-20.32%	-16.89%	-21.44%	-1.94%	9.45%	5.43%	26.40%	-16.24%	-3.77%	1.23%	-1.67%
Net Margin (Quarter)	-6.37%	-1.53%	2.35%	5.97%	-2.67%	-2.32%	-0.11%	-19.09%	-19.59%	-20.43%	-17.90%	-21.05%	-0.78%	9.34%	5.40%	26.38%	-14.85%	-3.33%	1.58%	-1.68%
FCF Margin (Quarter)	-26.83%	-6.14%	5.62%	29.20%	2.25%	-6.90%	18.78%	6.41%	-11.11%	-37.09%	4.41%	-1.43%	-12.97%	2.21%	-2.10%	2.08%	55.10%	3.96%	-11.39%	-9.12%
Efficiency
Assets Average (Quarter)	26.43M	27.85M	28.70M	31.44M	34.48M	34.88M	35.38M	36.26M	35.23M	32.11M	29.10M	27.54M	26.46M	25.53M	25.09M	27.93M	31.49M	31.45M	30.35M	29.30M
Equity Average (Quarter)	7.76M	7.48M	7.80M	8.65M	9.17M	9.04M	9.08M	8.12M	5.85M	3.27M	1.00M	-0.98M	-1.98M	-1.12M	0.17M	3.08M	4.62M	3.65M	3.88M	4.26M
Invested Capital (Quarter)	7.43M	7.54M	8.07M	9.24M	9.10M	8.98M	9.17M	7.06M	4.64M	1.90M	0.09M	-2.06M	-1.90M	-0.33M	0.68M	5.47M	3.77M	3.54M	4.23M	4.28M
Asset Utilization Ratio (Quarter)	1.55	1.53	1.55	1.49	1.42	1.48	1.53	1.48	1.53	1.64	1.72	1.79	1.90	2.02	2.14	2.10	1.81	1.81	1.92	1.98
Leverage & Solvency
Equity Ratio (Quarter)	0.27	0.27	0.28	0.28	0.26	0.26	0.25	0.20	0.14	0.06	0.00	-0.08	-0.07	-0.01	0.03	0.18	0.12	0.12	0.14	0.15
Valuation
Enterprise Value (Quarter)		-4.00M		-8.70M			-10.83M			-4.90M	-5.51M	-4.50M	-2.62M	-2.89M	-2.75M	-3.20M	-9.79M	-10.27M	-8.46M	-7.00M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	2.40%	1.03%	2.60%	1.69%	3.57%	2.73%	1.45%	-19.70%	-38.94%	-64.16%	-116.39%	-172.40%	-149.54%	-54.55%	-12.64%	77.99%	59.65%	30.83%	26.18%	-30.43%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.02%	-0.10%	0.10%	0.04%	0.03%	-0.04%	0.02%	0.01%	0.01%	0.01%	-0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.02%	-0.10%	0.10%	0.04%	0.03%	-0.03%	0.02%	0.01%	0.01%	0.01%	-0.01%

Research Tools

Champions Oncology Ratios (2010-2026) | CSBR

Create an account

Sign In

Reset Password